268 related articles for article (PubMed ID: 9136527)
1. [A comparative study of the quality of SPECT images obtained by 123I-IMP, 99mTc-HMPAO and 99mTc-ECD].
Odano I; Ohkubo M; Takahashi M; Noguchi E; Ohtaki H; Kasahara T; Shibaki M; Hatano M
Kaku Igaku; 1997 Mar; 34(3):189-94. PubMed ID: 9136527
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of cerebral vasoreactivity to acetazolamide in normal volunteer among 123I-IMP, 99mTc-ECD and 99mTc-HMPAO].
Makino K; Masuda Y; Gotoh S
Kaku Igaku; 1996 May; 33(5):551-5. PubMed ID: 8699624
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-HMPAO, technetium-99m-ECD and iodine-123-IMP cerebral blood flow measurements with pharmacological interventions in primates.
Dormehl IC; Oliver DW; Langen KJ; Hugo N; Croft SA
J Nucl Med; 1997 Dec; 38(12):1897-901. PubMed ID: 9430465
[TBL] [Abstract][Full Text] [Related]
4. Acetazolamide challenge and technetium-99m-ECD versus iodine-123-IMP SPECT in chronic occlusive cerebrovascular disease.
Ohnishi T; Yano T; Nakano S; Jinnouchi S; Nagamachi S; Flores LI; Nakahara H; Watanabe K
J Nucl Med; 1997 Sep; 38(9):1463-7. PubMed ID: 9293809
[TBL] [Abstract][Full Text] [Related]
5. SPECT images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases: comparison with other cerebral perfusion tracers and PET.
Tsuchida T; Nishizawa S; Yonekura Y; Sadato N; Iwasaki Y; Fujita T; Matoba N; Magata Y; Tamaki N; Konishi J
J Nucl Med; 1994 Jan; 35(1):27-31. PubMed ID: 8271056
[TBL] [Abstract][Full Text] [Related]
6. Comparative SPECT study of stroke using Tc-99m ECD, I-123 IMP, and Tc-99m HMPAO.
Matsuda H; Li YM; Higashi S; Sumiya H; Tsuji S; Kinuya K; Hisada K; Yamashita J
Clin Nucl Med; 1993 Sep; 18(9):754-8. PubMed ID: 8403717
[TBL] [Abstract][Full Text] [Related]
7. "Luxury perfusion" with 99mTc-HMPAO and 123I-IMP SPECT imaging during the subacute phase of stroke.
Moretti JL; Defer G; Cinotti L; Cesaro P; Degos JD; Vigneron N; Ducassou D; Holman BL
Eur J Nucl Med; 1990; 16(1):17-22. PubMed ID: 2307169
[TBL] [Abstract][Full Text] [Related]
8. [Difference in the distribution of 123I-IMP and 99mTc-HMPAO in the striatum--comparison with 15O-PET].
Otsuka M; Ichiya Y; Kuwabara Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
Kaku Igaku; 1993 Apr; 30(4):389-95. PubMed ID: 8315889
[TBL] [Abstract][Full Text] [Related]
9. [Quantitation of regional cerebral blood flow by single photon emission computed tomography of CBF-tracer combined with whole-brain CBF: a comparison between 123I-IMP and 99mTc-HMPAO in healthy volunteers].
Isaka Y; Imaizumi M; Ashida K; Ohe Y; Okamoto M; Abe T; Tanaka S
Kaku Igaku; 1994 May; 31(5):423-9. PubMed ID: 8028214
[TBL] [Abstract][Full Text] [Related]
10. A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime.
Matsuda H; Yagishita A; Tsuji S; Hisada K
Eur J Nucl Med; 1995 Jul; 22(7):633-7. PubMed ID: 7498224
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of 99mTc-ECD SPECT in diseases of the central nerve system: special reference to a comparison with 123I-IMP and 99mTc-HM-PAO SPECT].
Ono S; Yanagimoto S; Mimura H; Otsuka N; Nagai K; Morita K; Tomomitsu T; Muranaka A; Watanabe A; Ishii R
Kaku Igaku; 1992 Dec; 29(12):1429-40. PubMed ID: 1491488
[TBL] [Abstract][Full Text] [Related]
12. Quantitative 123I IMP and 99mTc HMPAO imaging in the dog following cocaine administration.
Susskind H; Weber DA; Ivanovic M; Wong CT; DeHaan CE; Gavin PR
Nucl Med Biol; 1996 Apr; 23(3):343-52. PubMed ID: 8782246
[TBL] [Abstract][Full Text] [Related]
13. [Intrasubject comparison of regional cerebral blood flow between N-isopropyl-p-[123I]iodoamphetamine SPECT and 99mTc-hexamethylpropyleneamine oxime SPECT in patients with ischemic cerebrovascular disease].
Isaka Y; Yoshikawa T; Ohe Y; Nakayama H; Abe T; Ashida K; Imaizumi M; Tanaka S
Kaku Igaku; 1995 Feb; 32(2):131-8. PubMed ID: 7715098
[TBL] [Abstract][Full Text] [Related]
14. Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison.
Asenbaum S; Brücke T; Pirker W; Pietrzyk U; Podreka I
J Nucl Med; 1998 Apr; 39(4):613-8. PubMed ID: 9544665
[TBL] [Abstract][Full Text] [Related]
15. Nonlinearity correction of brain perfusion SPECT based on permeability-surface area product model.
Tsuchida T; Yonekura Y; Nishizawa S; Sadato N; Tamaki N; Fujita T; Magata Y; Konishi J
J Nucl Med; 1996 Jul; 37(7):1237-41. PubMed ID: 8965204
[TBL] [Abstract][Full Text] [Related]
16. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
[TBL] [Abstract][Full Text] [Related]
17. SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD.
Koyama M; Kawashima R; Ito H; Ono S; Sato K; Goto R; Kinomura S; Yoshioka S; Sato T; Fukuda H
J Nucl Med; 1997 Apr; 38(4):587-92. PubMed ID: 9098207
[TBL] [Abstract][Full Text] [Related]
18. Database of normal human cerebral blood flow measured by SPECT: I. Comparison between I-123-IMP, Tc-99m-HMPAO, and Tc-99m-ECD as referred with O-15 labeled water PET and voxel-based morphometry.
Ito H; Inoue K; Goto R; Kinomura S; Taki Y; Okada K; Sato K; Sato T; Kanno I; Fukuda H
Ann Nucl Med; 2006 Feb; 20(2):131-8. PubMed ID: 16615422
[TBL] [Abstract][Full Text] [Related]
19. [The semiquantitative measurement method of cerebral blood flow using SPECT image].
Boku A
Hokkaido Igaku Zasshi; 1995 May; 70(3):413-27. PubMed ID: 7590593
[TBL] [Abstract][Full Text] [Related]
20. [Cerebral perfusion scintigraphy in patients with cerebrovascular disease by using 99mTc-ECD: comparative study with 123I-IMP SPECT].
Ogawa Y; Nishimura T; Hayashida K; Yokota I; Imakita S; Kumita S; Uehara T; Shimonagata T; Oka H; Nakamura M
Kaku Igaku; 1991 Jun; 28(6):599-607. PubMed ID: 1895556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
